Twice As Nice: Seattle Genetics, Merck & Co. Partner On Two Cancer Drugs

Companies Will Jointly Develop A Novel ADC And Commercialize Tukysa

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.